Drug Profile
Research programme: encapsulated pancreatic islets - Encapsulife
Alternative Names: Bio-artificial pancreas - Encapsulife; Encapsulated cell therapy-diabetes - EncapsulifeLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Encapsulife
- Developer Encapsulife; Harvard Medical School; Vanderbilt University
- Class Cell therapies
- Mechanism of Action Pancreatic beta cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Type 1 diabetes mellitus; Type 2 diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Type-1 diabetes mellitus in USA (SC, Patch)
- 16 Jul 2016 No recent reports of development identified for research development in Type-2-diabetes-mellitus in USA (SC, Patch)
- 15 Feb 2008 Early research in Type-2 diabetes mellitus in USA (SC)